(p<0.5). The results indicate that 'stiff' and heavy lungs occur in experimental acute pancreatitis. The fact that these changes are abolished by heparin and improved by aspirin suggests that intrapulmonary fibrin deposition is a factor in the pathogenesis of the important respiratory complications of this condition.
Clinical and radiological changes occurring within the lung and pleural cavities in patients with acute pancreatitis are well recognised' and the poor prognosis associated with these complications when accompanied by hypoxaemia has been emphasised? 3 Ranson et al4 and Imrie et a15 pointed out that significant hypoxaemia (P02<8-9 kPa) often occurred without clinical or radiological evidence of respiratory embarrassment.
Destruction of the alveolar lining substance surfactant612 has been proposed as a likely mechanism for the pulmonary damage, though this may not be the sole mechanism involved. The respiratory features of acute pancreatitis are those of adult respiratory distress syndrome (ARDS)13 in which intrapulmonary fibrin deposition has been incriminated.14 l As coagulation disturbances are also well established in acute pancreatitisl6Q9 they may be instrumental in causing the pulmonary changes, as has been suggested by Ranson et al.20 Granulocyte aggregation induced by inappropriate complement activation has also been impli-cated in the pathogenesis of adult respiratory distress syndrome;21 moreover it has been shown that this phenomenon can be inhibited by corticosteroids. As complement activation has been shown in acute pancreatitis23 24 the mechanisms may also be instrumental in causing the respiratory complications of the disease.
In view of the proven association between the prognosis in acute pancreatitis and the respiratory complications,2-5 an understanding of the lung changes which occur is fundamental and any therapy that can be shown to prevent or reverse these changes will represent a major advance in the management of this difficult-to-treat condition. This study describes the changes in the biophysical properties of lung which occur in a rat model of acute pancreatitis and investigates the effects of dexamethasone, heparin, and aspirin on these changes.
Methods
Adult Sprague Dawley rats weighing between 250 and 350 g were fasted for 24 hours, but given free access to water. General anaesthesia was induced with intraperitoneal pentabarbitone (Sagatal, strength 60 mg/ml), which was diluted with ethyl alcohol to a 10% solution and administered in a dose 481 of 0O75 ml per 100 g body weight. Surgical anaesthesia occurred within five minutes. Acute pancreatitis was induced according to the method described by Chetty et al. 25 Briefly, the method involves forming a closed duodenal loop around a piece of 10 gauge plastic tubing which maintains intestinal continuity. Human T-tube bile was injected into the closed loop and produced pancreatitis by refluxing along the pancreatic ducts under pressure.
Five groups of eight rats were studied: (1) sham gastrotomy, (2) acute pancreatitis, (3) acute pancreatitis given dexamethasone (3 mg/kg intravenously), (4) acute pancreatitis given heparin (150 i,u/kg subcutaneously or intravenously), (5) acute pancreatitis given aspirin (20 mg/kg enteric). All drugs were administered at the end of the operative procedure. After six hours all rats were anaesthetised as previously described, blood was taken for serum amylase estimation, and the rats were exsanguinated. Amylase estimations were performed by the Phadebas technique (Pharmacia).
After the rats had been killed, the lungs were carefully removed and inflated with 10 ml of air and then deflated. Inflation/deflation pressures were measured at 0.5 ml intervals using a three-way tap and a water manometer. The lungs were then cleaned and weighed. Lung compliance was calculated from the gradient of the curve, produced by plotting lung volume against intrapulmonary pressure, over the first 5 ml of a slow deflation from a maximum inflation as recommended26 (Fig. 1) .
Results
Pancreatitis was confirmed by raised serum amylase levels in all groups except group 1 (Table) (Fig.  3 ).
There was no difference between the effects of heparin given intravenously (four rats) or subcutaneously (four rats) and no bleeding problems were encountered.
Discussion
The marked rise of serum amylase levels seen in all except the control sham operation group confirms tion are involved and presumably are effective by changing the structure of the alveolar wall.
The increase in lung weight and decrease in lung compliance produced in the pancreatitis group were completely abolished by a low dose of heparin (p<0.01) administered either intravenously or subcutaneously without evidence of increased bleeding. Aspirin also significantly improved lung weight changes (p<005). Though the differences between heparin and aspirin were not significant, the latter did not appear to be as effective as heparin in reversing lung weight changes but appeared to be slightly more effective than heparin in reversing the changes in lung compliance produced by pancreatitis (p<0.001). These results suggest that intrapulmonary fibrin deposition and intravascular coagulation are involved in the pathogenesis of the pulmonary changes. The deposition may result from a trypsin-induced increase in fibrinogen activation or from the action of inhibitors of normal fibrinolysis. The mechanism by which fibrin deposition causes lung damage is not fully understood, though the local release of fibrin(ogen) degradation products, which cause an increase in capillary permeability27 and may cause platelet aggregation,28 has been suggested as the likely important factor. Vasoactive peptides, particularly fibrinopeptide-A, which are released during the conversion of fibrinogen to fibrin are known to be vasoactive and have also been implicated. 29 Dexamathasone abolished the changes in lung compliance (p<002), while having no effect on the increased lung weight (p>0.5) in the pancreatitis group, which implies that more than one factor is involved in the pathogenesis of these respiratory complications. So diverse are the effects of corticosteroids that it is difficult to interpret their action here, but if complement-induced granulocyte aggregarion is involved21 it is clearly not the sole mechanism. The use of steroids is further complicated by the fact that they have been implicated as one of the aetiological factors in acute pancreatitis. 30
In conclusion, using an animal model, pulmonary changes were produced in experimental acute pancreatitis. These were a decrease in lung compliance and an increase in lung weight. These changes were abolished by low dose heparin and improved by enteral aspirin. Though other factors such as surfactant denaturation and inappropriate complement activation may contribute to the respiratory changes of acute pancreatitis, these results suggest that intrapulmonary fibrin deposition is of major importance. As poor prognosis is closely related to the development of respiratory complications in acute pancreatitis, low dose heparin may have an important role to play in the management of patients with this difficult condition; though it must be emphasised that, in this study, treatment was given at the onset of disease and this is clearly not a clinical possibility. 
